EGR1 and non-small cell lung carcinoma: Our data revealed that α-Hederin promotes EGR1 translocation to the nucleus and directly binds to the miR-96-5p promoter region, thus suppressing miR-96-5p and sensitizing the NSCLC cells to cisplatin.